BioSyntech, Inc.
BSYI
$0.00
$0.000.00%
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | 7.62% | -0.99% | -74.24% | -86.94% | -12.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.62% | -0.99% | -74.24% | -86.94% | -12.20% |
| Cost of Revenue | -6.12% | -13.45% | -74.27% | -85.69% | -17.11% |
| Gross Profit | 16.82% | 7.06% | -74.18% | -87.57% | -8.70% |
| SG&A Expenses | 3.54% | -11.22% | -26.33% | -20.73% | -14.13% |
| Depreciation & Amortization | -9.45% | -16.56% | -13.05% | -11.78% | 12.11% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.39% | -31.49% | -32.74% | -21.06% | -2.89% |
| Operating Income | 30.11% | 32.11% | 31.50% | 19.07% | 2.69% |
| Income Before Tax | 1.13% | -17.45% | -22.56% | -26.61% | -31.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.13% | -17.45% | -22.56% | -26.61% | -31.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.13% | -17.45% | -22.56% | -26.61% | -31.02% |
| EBIT | 30.11% | 32.11% | 31.50% | 19.07% | 2.69% |
| EBITDA | 30.51% | 32.17% | 31.57% | 19.07% | 1.93% |
| EPS Basic | 7.66% | -12.87% | -20.68% | -26.06% | -30.41% |
| Normalized Basic EPS | 1.04% | 1.68% | -4.93% | -9.64% | -17.75% |
| EPS Diluted | 7.66% | -12.87% | -20.68% | -26.06% | -30.41% |
| Normalized Diluted EPS | 1.04% | 1.68% | -4.93% | -9.64% | -17.75% |
| Average Basic Shares Outstanding | 6.80% | 4.35% | 1.96% | 0.43% | 0.36% |
| Average Diluted Shares Outstanding | 6.80% | 4.35% | 1.96% | 0.43% | 0.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
